Rahhab Zouhair, El Faquir Nahid, Rodríguez-Olivares Ramón, Ren Claire, van Mieghem Nicolas, Geleijnse Marcel L, Schultz Carl, van Domburg Ron, de Jaegere Peter P
Department of Cardiology and Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Cardiology, Royal Perth Hospital Campus, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
J Cardiovasc Surg (Torino). 2017 Aug;58(4):598-605. doi: 10.23736/S0021-9509.17.09391-0. Epub 2017 Jan 27.
The aim of this paper was to explore the determinants of aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) using multi-slice computed tomography (MSCT) instead of echocardiography-guided sizing.
Determinants of AR were assessed in 313 consecutive patients who underwent TAVI with the Medtronic (MCS, N.=259) or Edwards Sapien or XT (ESV, N.=54) using MSCT-guided sizing. AR was assessed by angiography immediately after TAVI (N.=313, Sellers) and by echocardiography at discharge (N.=285, VARC-2). Distinction was made between patients with grade 0-1 and grade ≥2 AR post-TAVI.
AR≥2 post-TAVI was seen in 91 patients or 29% (MCS 85/259: 33% vs. ESV 6/54:11%) by angiography and 94 patients or 33% (MCS 87/239:36% vs. ESV 7/46:15%) by echocardiography. By univariable analysis, patients with AR≥2 post TAVI had more AR≥2 at baseline (70% vs. 52%, P=0.003), a larger mean and maximal annulus diameter (25.0 [23.5-26.3] vs. 24.0 [22.6-26.0], P=0.025 and 27.9±2.7 mm vs. 27.0±2.8 mm, P=0.018, respectively) and a higher Agatston Score (3.9 [2.9-5.3] vs. 2.6 [1.8-3.8], P≤0.001). AR≥2 post-TAVI was more frequent after MCS than ESV (33% vs. 11%, P=0.001). There was no difference in nominal valve size relative to the patient's annulus, nor depth of implantation. By propensity score adjusted multivariable analysis, AR≥2 at baseline (odds 2.407 [95% CI: 1.472-3.938]) but above all MCS (odds: 6.047 [95% CI; 1.307- 27.976]) were independent determinants of AR≥2 post-TAVI. The latter was also confirmed by propensity score adjusted multivariable analysis in the echocardiography population (N.=285) (odds: 5.259 [95% CI; 1.070-25.851]).
AR≥2 is more prevalent after MCS valve implantation and is an independent determinant of AR also when using MSCT guided-sizing.
本文旨在探讨使用多层螺旋计算机断层扫描(MSCT)而非超声心动图引导尺寸测量的经导管主动脉瓣植入术(TAVI)后主动脉瓣反流(AR)的决定因素。
对313例连续接受TAVI的患者进行评估,这些患者使用美敦力(MCS,n = 259)或爱德华兹Sapien或XT(ESV,n = 54)瓣膜并采用MSCT引导尺寸测量。TAVI术后立即通过血管造影(n = 313,Sellers法)评估AR,并在出院时通过超声心动图(n = 285,VARC-2标准)评估AR。区分TAVI术后AR分级为0-1级和≥2级的患者。
血管造影显示TAVI术后AR≥2级的患者有91例,占29%(MCS组85/259:33% vs. ESV组6/54:11%);超声心动图显示94例,占33%(MCS组87/239:36% vs. ESV组7/46:15%)。单因素分析显示,TAVI术后AR≥2级的患者基线时AR≥2级的比例更高(70% vs. 52%,P = 0.003),平均和最大瓣环直径更大(分别为25.0 [23.5 - 26.3] vs. 24.0 [22.6 - 26.0],P = 0.025;27.9±2.7 mm vs. 27.0±2.8 mm,P = 0.018),阿加斯顿积分更高(3.9 [2.9 - 5.3] vs. 2.6 [1.8 - 3.8],P≤0.001)。MCS瓣膜植入后TAVI术后AR≥2级比ESV更常见(33% vs. 11%,P = 0.001)。相对于患者瓣环的标称瓣膜尺寸和植入深度无差异。通过倾向评分调整的多因素分析,基线时AR≥2级(比值比2.407 [95%可信区间:1.472 - 3.938]),但最重要的是MCS瓣膜(比值比:6.047 [95%可信区间;1.307 - 27.976])是TAVI术后AR≥2级的独立决定因素。在超声心动图人群(n = 285)中,倾向评分调整的多因素分析也证实了这一点(比值比:5.259 [95%可信区间;1.070 - 25.851])。
MCS瓣膜植入后AR≥2级更普遍,并且在使用MSCT引导尺寸测量时也是AR的独立决定因素。